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Background/Objectives: Although a high proportion of older Americans are at risk for 
obstructive sleep apnea (OSA), the magnitude of OSA under-diagnosis and under-treatment 
within this rapidly expanding population is unknown. The objective of this study was to estimate 
the proportion of older Americans at elevated risk for OSA who receive OSA evaluations, 
diagnosis, and treatment.    
Design, Setting and Participants: Data were obtained from Round 3 of the National Health and 
Aging Trends Study, a nationally representative annual survey of community-dwelling Medicare 
beneficiaries linked to Medicare fee-for-service claims. One third of Round 3 participants, 
selected at random, were administered specific questions about sleep disturbances, including 
items that resembled key elements of a validated instrument used to assess OSA risk (the STOP-
Bang questionnaire). 
Intervention: none. 
Measurements: The proportion of older Americans at-risk for OSA who received evaluations 
with home or in-laboratory sleep studies, OSA diagnosis, and OSA treatment. Clinical, social, 
and demographic correlates of OSA were also examined. 
Results:  Among 1,052 participants who completed the sleep module, 56% (95% CI: 53%,59%) 
were estimated to be at elevated risk for OSA. Only 8% (95% CI: 5%,11%) of the elevated risk 
individuals had been tested for it. Among those tested, 94% (95% CI: 87%,100%) were 
diagnosed with OSA. Treatment with positive airway pressure was prescribed for 82% (95% CI: 
65%, 99%) of participants with an OSA diagnosis. 
Conclusions: Evidence from this nationally representative sample of community dwelling 
Medicare beneficiaries suggests that increased OSA risk is common, but seldom investigated. 
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When investigated, OSA is almost always confirmed and usually treated. These findings suggest 
a significant gap in OSA assessment for older Americans that could have public health 
implications.   
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Obstructive sleep apnea (OSA) is a disorder characterized by repeated episodes of upper-
airway obstruction during sleep. A major public health threat, OSA is associated with far-









 motor vehicle accidents,
11
 and diminished quality of life.
12
 
Healthcare costs of OSA and its associated morbidity  are likely to be substantial. 
13, 14
 
Adults age 65 and older constitute 14.9% of the U.S. population.
15
 Although older age is 
a recognized risk factor for OSA, estimates regarding OSA risk, and discrepancies in OSA 
recognition and treatment are primarily based on regional data from middle-aged adults.
16-20
 
Little is known about the national scope of OSA risk, under-recognition, and under-treatment in 
older adults. These limitations represent gaps in knowledge, as older Americans are more likely 
to experience many of the costly, preventable health consequences associated with OSA,
21-23
 and 
this demographic is expected to constitute 21.7% of the U.S. population by 2040.
24
  To better 
characterize the national health burden of OSA, inform initiatives to reduce this burden, and 
optimize health outcomes for one of the primary consumers of health services in the U.S., an 
improved understanding of the scope and treatment patterns of OSA among older persons  is 
necessary.  
The purpose of this study was to determine the proportion of older Americans at-risk for 
OSA within a large, representative sample of Medicare beneficiaries, and to characterize the 
national scope of gaps in OSA evaluation, diagnosis and treatment among these at-risk 
individuals. We hypothesized that, in comparison to general population estimates, a higher 
proportion of older individuals would be at-risk for OSA, but that these individuals would be less 
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likely to receive OSA evaluations. As an exploratory analysis, social, clinical, and demographic 
factors associated with OSA diagnosis among older Americans were also evaluated. 
 
METHODS 
All study procedures were approved by the University of Michigan Institutional Review Board 
(IRBMED).   
Data sources and study population 
National Health and Aging Trends study: Data were obtained from Round 3 of the National 
Health and Aging Trends Study (NHATS), a nationally representative, longitudinal survey of 
Medicare beneficiaries designed to assess the impact of aging (http://www.nhats.org/). Funded 
by the National Institute on Aging (U01AG032947), NHATS has performed annual face-to-face 
interviews in beneficiaries’ residencies since 2011. NHATS’ protocol includes assessment of 
physical and cognitive capacity measures, specific health conditions, disability, pain, mood, 
symptom severity and frequency, well-being, mobility, accommodations, self-care, social 
support activities, demographics, and socioeconomic characteristics. Proxy respondents are used 
if a participant is unable to answer NHATS questions. Completed with an 88% response rate,
25
 
Round 3 included interviews from 5,097 participants, who, through survey weights, represented 
32,639,407 older Americans. Survey weights accounted for differential selection probabilities 
and potential non-response bias.    
NHATS Sleep module:  In 2013, NHATS also asked questions about sleep disturbances and 
symptoms of sleep-disordered breathing.  Six of these “sleep module” items, which closely 
resemble items of the STOP-Bang questionnaire, 
26
 were adapted for use in this study. The 
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STOP-Bang is a validated, 8-item screening instrument that assesses characteristics known to 
confer risk for OSA, and form the acronym “STOP-BANG” (Snoring, Tiredness, Observed 
apneas, high blood Pressure, BMI, Age, Neck circumference, Gender). Item scores (1/0) are 
based on yes/no answers.
27, 28
  The sensitivity of a STOP-Bang score of ≥3 as the cut-off to 
predict any OSA [apnea hypopnea index (AHI) >5], moderate-to-severe OSA (AHI >15), or 
severe OSA (AHI >30) was demonstrated to be 83.9%, 92.9% and 100% respectively.
28
  In 
general, scores of 0-2 are considered low-risk; scores of 3-4 are considered “elevated” risk; and 
scores of >=5 (or, scores of 3 that include specific combinations of STOP-Bang items) are 
considered high-risk.
29
  The utility of the STOP-Bang has been widely demonstrated in a variety 
of large patient samples, many of which included high proportions of elderly patients.
27, 30-34
 The 
NHATS sleep module was administered to a random subset of n=1,052 Round 3 participants, 
which through sampling weights, corresponds to 7,082,963 beneficiaries (Figure 1). Responses 
to sleep-specific items from this module were used to estimate the proportion of Medicare 
enrollees who were at-risk for OSA. For primary analyses, participants were considered to be at-
risk for OSA if they scored ≥ 3 points on the surrogate NHATS STOP-Bang items 
(supplementary Table S1).  As all respondents scored at least “1” on the STOP-Bang based on 
the age item (> 50 years old, which could differentially affect estimation of OSA risk within our 
pool of respondents), an additional dataset in which the age item was dropped from the score was 
also created for exploratory analyses.  Additional NHATS sleep module items included questions 
about initial and sleep maintenance insomnia, sleep duration, hypnotic use, napping frequency, 
and napping duration (supplementary Table S2).   
Linkage to claims data: NHATS data were linked to Medicare fee-for-service claims files to 
identify sleep module participants (n=1,052) who received formal OSA evaluations, diagnosis 
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and treatment. The linked dataset allowed us to estimate the proportion of beneficiaries whose 
claims included CPT codes for in-laboratory polysomnography (PSG, the gold standard method 
for OSA diagnosis) or home sleep apnea testing (HSAT), an ICD-9 coded OSA diagnosis, and 
HCPCS codes for positive airway pressure (PAP) equipment (supplementary Table S3).  To 
minimize the likelihood of including prevalent OSA cases diagnosed before 2011, beneficiaries 
with existing PAP claims or OSA diagnosis codes who did not have PSG/ HSAT claims during 
the 2011-2013 observation period were excluded from analyses. 
Statistical methods 
Descriptive statistics procedures for complex survey data (chi-square) were used to 
examine demographic and health characteristics for all Round 3 participants with linked fee-for-
service claims. Among sleep module participants with available claims, for primary analyses, we 
estimated: 1) the proportion of participants at elevated risk for OSA (i.e. ‘at-risk’); 2) the 
proportion of ‘at-risk’ participants who were evaluated for OSA with HSAT or in-laboratory 
PSG; 3) the proportion of ‘at-risk’ participants diagnosed with OSA following HSAT or PSG; 
and 4) the proportion of ‘at-risk’ participants with OSA who were prescribed PAP treatment. 
These steps were repeated for low-risk participants (surrogate STOP-Bang score ≤ 2).  
         Bivariate logistic regression models were constructed to examine associations of clinically 
relevant characteristics postulated to be associated with ICD-9-coded OSA diagnoses across the 
full Round 3 fee-for service Medicare linked sample (n=3,195).  
Clinically relevant independent variables associated with OSA diagnosis (p-value <0.15 
in bivariate analyses) were included in a multivariable logistic regression model with OSA 
diagnosis as the dependent variable. Independent variables included: age (categorical), sex, 
marital status, presence of bothersome pain, body mass index (BMI), use of a mobility device, 
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diabetes, and cardiovascular disease, a composite variable defined as a positive response if 
participants endorsed one or more of the following conditions: hypertension, congestive heart 
failure, myocardial infarction, or stroke.  
Bivariate logistic regression models were also used to explore other characteristics not 
captured in the STOP-Bang items (comorbidities, independent mobility) that could influence the 
likelihood of OSA evaluation with sleep studies among at-risk respondents. 
  
All analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC).  
 
RESULTS 
Inclusion and exclusion criteria, and sample sizes of Round 3 and sleep module 
participants are presented in a flowchart (supplementary Figure S4).  Demographic and clinical 
characteristics of the 3,195 live NHATS participants are described in Table 1.  
Among the 1,052 sleep module participants, 56% (95% CI: 53-59%) were ‘at-risk’ for 
OSA based on a surrogate STOP-Bang score of 3 or more. Among these at-risk individuals, only 
8% (95% CI: 5-11%) received OSA evaluation with PSG or HSAT. The majority - 94% (95% 
CI: 87-100%) of those evaluated - received an ICD-9-coded OSA diagnosis, and of those, 82% 
(95% CI: 65-99%) were prescribed PAP equipment (Figure 1). Among the remainder of 
respondents (44%) with surrogate STOP-Bang scores of 2 or less, 2% received OSA evaluations 
(95% CI: 0.8-4%).  Of those, 90% received an ICD-9 coded OSA diagnosis (95% CI: 88-92%) 
and 50% were prescribed PAP equipment (95% CI: 38-62%). Table 2 summarizes the proportion 
of sleep module participants who received OSA testing based on each surrogate STOP-Bang 
score. Proportions of respondents who endorsed additional sleep-related symptoms or 
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characteristics (outside of the STOP-Bang), and likelihood of evaluation, are summarized in 
supplementary Table S2.   
Upon recalculation of OSA risk with the age item dropped from the surrogate STOP-
Bang score, (supplementary Figure S5), the proportion of at-risk respondents remained high 
(20%), and, among this 20%, 13% received a sleep study (87% of those at risk for OSA did not 
receive a sleep study).  Nearly all of the 13% of patients in this group who underwent sleep 
studies were diagnosed with OSA (94%).  
In analyses of Round 3 sample (n=3,195), older age, male sex, marital/cohabitant status, 
higher BMI, use of a mobility device, pain, cardiovascular disease, and diabetes were 
independently associated with OSA diagnosis, but education, race, and depressive symptoms 
were not (Table 3). Multivariate models suggested significant associations between OSA 
diagnosis, male sex, and BMI.      
 Bivariate analyses compared characteristics - those with potential to influence the 
likelihood of OSA evaluation with PSG or HSAT -- between the 92% of unevaluated 
respondents and the 8% who were evaluated. Independent drivers and those who needed help 
“getting around and outside the house” were more likely to be evaluated. Beneficiaries with 
BMI>30 were also more likely to be evaluated. OSA evaluation was not associated with 
presence of dementia, depression, diabetes, pain, cancer or stroke.  
 
DISCUSSION 
This study of a nationally representative sample of Medicare beneficiaries suggests that a 
large proportion of older Americans who are at increased risk for OSA do not receive 
evaluations for this condition. Using NHATS items that resemble the STOP-Bang questionnaire, 
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56% were found to be at increased risk for OSA.  Excluding age as a risk factor, 20% of older 
beneficiaries still met criteria for elevated OSA risk.  Among at-risk individuals who received 
evaluations with PSG or HSAT, nearly all (94%) received a diagnosis of OSA, and 82% of these 
individuals received treatment with positive airway pressure.  Our study provides new evidence 
that, among older Americans, increased risk for OSA is common, seldom investigated, and when 
investigated, usually confirmed and treated.  These data also invite speculation that older 
individuals may be vulnerable to disparities in clinical evaluation for OSA. Follow-on work that 
validates the full STOP-Bang questionnaire and demonstrates health consequences that may be 
offset by efficient OSA detection among older individuals will be necessary to shape future OSA 
screening guidelines for geriatric patients; however, these data provide an important first step in 
highlighting the national scope of OSA risk, recognition, and treatment among older Americans.   
 .  The national magnitude and impact of OSA under-evaluation in the U.S., particularly 




 Perhaps the most comprehensive study of sleep-
disordered breathing and predictive clinical correlates that focused solely on older Americans 
was completed in the 1980s.  In this study, Ancoli-Israel and colleagues conducted interviews 
and HSAT in older San Diego residents.
38
 Depending on HSAT measures used, at least 24% had 
evidence of sleep-disordered breathing.  In keeping with the STOP-Bang, features most reliably 
associated with sleep-disordered breathing included BMI, male gender, and sleepiness 
frequency.  In the Sleep Heart Health Study – a cohort study designed to investigate OSA as a 
risk factor for cardiovascular diseases 
39
– older adults accounted for approximately 60% percent 
of the sample.  In the same study, male gender, snoring and breathing pauses were also identified 
as predictors of OSA.
20
  However, the scope of national gaps of OSA evaluation among older 
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patients was not a focus of these studies, and factors that may prompt or dissuade providers from 
referring older patients for OSA evaluations have not been sufficiently explored. 
Although traditional correlates of OSA (snoring, sleepiness, hypertension) are recognized 
triggers for PSG and HSAT in the general population,
40
 many of these characteristics are also 
attributed to normal aging. Consequently, older patients who exhibit these characteristics may be 
more likely than their middle-aged counterparts to escape sleep evaluations. Older patients may 
also be less likely to seek medical attention for symptoms that signal OSA in younger 
individuals,
20
 or more likely to experience sequelae not classically associated with OSA in 
younger patients.
4, 41-44
  Accordingly, our analyses also examined factors associated with OSA 
diagnosis (and likelihood of evaluation) outside of the STOP-Bang construct across the entire 
sample of n=3,195 participants.  In keeping with previous studies,
38, 45
 male gender and BMI 
remained strong predictors of OSA diagnosis. Additional noteworthy correlates of OSA 
diagnosis included the presence of bothersome pain, use of a mobility device, diabetes, and 
married/cohabitation status (table 3), as well as poor overall health and independent use of a 
vehicle (Results).  Potential factors associated with the likelihood of OSA evaluation included 
independent use of a vehicle and need for mobility assistance in and around the house. The 
above associations allow speculation that characteristics not captured by the STOP-Bang, 
including symptoms associated with sleep disturbances (pain), input from a bed 
partner/caregiver, or transportation barriers could confer OSA risk or influence likelihood of 
evaluation among older adults. In this regard, other sleep-specific characteristics queried by the 
NHATS sleep module such as insomnia, short sleep duration, or frequency of hypnotic use 
(supplementary Table S2) could explain the high prevalence of OSA diagnosis among the 2% of 
low-risk respondents who received OSA evaluations with PSG or home sleep apnea tests. 
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Definitive conclusions cannot be drawn regarding snoring or hypersomnolence as predictors of 
OSA from our logistic regression models, as NHATS items pertaining to these symptoms were 
only given to participants in the sleep module which precluded their inclusion in logistic 
regression models. Furthermore, although only 8% of sleep module respondents were classified 
as snorers, complex item phrasing (see supplemental Table S1) may have dissuaded a positive 
response. Additional studies are necessary to assess the prevalence of snoring and its association 
with OSA among older Americans.   
These findings raise questions about the implications of OSA screening with the STOP-
Bang among older patients.  Although the STOP-Bang has not been formally validated in adults 
over age 65, previous validation studies that have included high numbers of older individuals,
27, 
30-32
 and the large proportion of respondents with surrogate STOP-Bang scores of 3 or more who 
received an OSA diagnosis (94%) following PSG or HSAT in this sample combine to suggest 
that this instrument could still offer adequate positive predictive value for OSA screening among 
older patients.   
Our findings also invite questions about the predictive value of other factors and 
symptoms outside of the STOP-Bang. For example, age-related weakness of pharyngeal dilator 
muscles, thought to arise from vibratory trauma to the oropharynx, is hypothesized to contribute 
to OSA risk in older adults.  Although snoring could contribute to this phenomenon, and is 
captured by the STOP-Bang, the STOP-Bang does not directly assess signs of pharyngeal muscle 
weakness.
46-48
 Furthermore, the STOP-Bang is designed to capture those who are male and 
obese, even though OSA is not strongly associated with a gender predilection in older 
individuals, and obesity is not as frequently encountered in the elderly.  Future research that 
focuses on assessment of additional predictors of OSA not included in the STOP-Bang as 
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screening tools could reduce the underestimation of this condition among older women and non-
obese adults. 
Although additional studies are necessary to determine whether complications of OSA 
among older adults parallel those of middle aged adults, recent studies that have included older 
subjects would suggest that a substantial proportion of older patients, and males in particular, 
may be subject to the same cardiovascular risks and all-cause mortality.
49-51
  Furthermore, older 
patients may be more vulnerable to other OSA-related consequences, including falls, cognitive 
impairment or dementia. 
52-54
 Prior work demonstrates a link between OSA and cognitive 
dysfunction in dementia patients,
55
 and some studies suggest that CPAP may improve 
performance in specific cognitive domains, or delay cognitive decline.
55, 56
  Confirmation of  
benefits of CPAP on cognitive function and cardiovascular risk would provide support for 
population-based OSA screening for older adults. 
To our knowledge, this is the first study to characterize the national scope of OSA risk 
and likelihood of evaluation among older Americans. Strengths include a large representative 
sample of Medicare beneficiaries and high response rate (88%). Linkage of to Medicare fee-for-
service claims files allowed coupling of beneficiary characteristics (collected through in-person 
interviews) with objective claims data regarding PSG or HSAT, OSA diagnosis, and Medicare 
prescriptions of PAP equipment. The use of sampling weights allowed the generalization of 
results to the population.  
Potential limitations should be acknowledged. Although three of the six NHATS 
surrogate STOP-Bang items were objectively measured (age, gender, and BMI), the remaining 
items required reformatting to allow uniform scoring. Although these items closely resemble 
STOP-Bang items, these adapted items have not been validated formally. A possibility also 
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exists that absence of an neck circumference item could have excluded some at-risk participants.  
To examine the influence on overall OSA risk of allowance of two points for the NHATS 
snoring item (which queried the presence of snoring OR gasping/choking within the same item), 
we performed sensitivity analyses among subjects with positive responses to this item. Our 
analyses suggest that the majority of participants who were given two points for a positive 
snoring item (92%) would have still received a surrogate STOP-Bang score of ≥3, even if they 
were assigned only one point.  Additionally, when more specific but less sensitive STOP-Bang 
scoring methods were applied to our sleep module sample, 
57
 a similarly low proportion of at-risk 
participants (2%) were evaluated for OSA. Potential barriers to OSA evaluations among at-risk 
older patients require further exploration; that said, we acknowledge that clinical decisions to 
refer for PSG or HSAT could in part be influenced by data not available in NHATS. Finally, it is 
possible that excluding Medicare Advantage patients (36% of the sample) could reduce 
generalizability.   
Our data highlight a national gap in evaluation among one of the most rapidly growing 
demographics in the U.S.  If older individuals with OSA are subject to the same benefits of 
treatment as middle-aged adults, research that addresses potential causes and solutions for these 
gaps, and demonstrates the value of OSA screening among older patients, could offer a vital 
opportunity to improve one of the nation’s top health epidemics. 
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t Table 1: Demographic and health characteristics of NHATS Round 3 participants  Demographic and Health characteristics 









Sample Size N           3,195
b
           100 
Female 1,910 57 (1.0) 
Male 1,285 43 (1.0) 
Age 65-69 267 13 (0.8) 
Age 70-74 664 30 (0.9) 
Age 75-79 621 21 (0.8) 
Age 80-84 676 17 (0.7) 
Age 85-89 528 12 (0.6) 
Age 90+ 439 7 (0.5) 
White Non-Hispanic 2,348 84 (1.1) 
Black Non-Hispanic 626 7 (0.6) 
Hispanic, Asian, American-Indian,                    
Pacific Islander 
196 8 (0.8) 
Race missing 25 <1 (0.3) 
Less than high school 722 19 (1.0) 
High school 769 25 (0.8) 
Some college or vocational 737 25 (0.9) 
Bachelor’s degree or higher 780 28 (1.5) 
Educational status missing 187 <3 (0.3) 
Married 1,419 53 (1.0) 
Not married 1,608 45 (1.0) 
Marital status Missing 168 2 (0.2) 
Body Mass Index >35 238 8 (0.6) 
Body Mass Index ≤35 2,773 89 (0.7) 
Body Mass Index data missing 184 <3 (0.2) 
Cardiovascular disease 
c
 1,206 36 (1.1) 
No Cardiovascular disease 1,822 62 (1.2) 
Missing cardiovascular data 167 2 (0.2) 
Diabetes 802 25 (0.9) 
No diabetes 2,226 73 (0.9) 
Missing data on diabetes 167 2 (0.2) 
a 
Unweighted frequencies represent sample counts, weighted proportion represent corresponding 
population proportion (through sampling weights 3,195 respondents corresponds to 20,346,443 
beneficiaries) 
b
 Live participants who completed Round 3 NHATS interviews; 
c 
Cardiovascular disease 
represents a composite variable that includes one or more of the following: hypertension, myocardial 
infarction, congestive heart failure or stroke. 
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Table 2: Composition of OSA risk factors among  NHATS sleep module participants evaluated 
for OSA, within each surrogate STOP-Bang score category 
STOP-Bang 
Score (%) 
Male BMI>35 HTN Fatigue Snore Age Evaluated  OSA 
Diagnosis  
1 (10.8) 0 0 0 0 0 100% 1.4% 100% 
2 (33.4) 21% 1% 65% 12% 0 100% 3% 88% 
3 (35.5) 53% 8% 84% 51% 2% 92% 5% 93% 
4 (14.8) 78% 23% 96% 100% 11% 100% 12% 96% 
5 (3.2) 39% 22% 92% 81% 83% 100% 16% 83% 
6 (2.0) 76% 29% 100% 94% 100% 100% 11% 100% 
7 (0.3) 100% 100% 100% 100% 100% 100% 72% 100% 
BMI=Body Mass Index; HTN=Hypertension; Risk score=by STOP-Bang items 
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Table 3: Predictors of ICD-9 OSA diagnosis among all Round 3 NHATS fee-for-service 
participants
 
Predictors of OSA Bivariate Model   
Odds Ratio (95% CI) 
 
Multivariate Model                      
Odds Ratio (95% CI)
 
Age    
65-69 Reference Reference 
70-74 0.8 (0.5, 1.3) 0.9 (0.5, 1.4) 
75-79 0.8 (0.5, 1.2) 0.9 (0.5, 1.5) 
80-84 0.6 (0.3, 0.9) 0.8 (0.4, 1.3) 
85-89 0.5 (0.3, 0.8) 0.8 (0.4, 1.5) 
90+ 0.2 (0.1, 0.5) 0.4 (0.2, 1.0) 
Sex   
Male 1.4 (1.0, 1.9) 1.4 (1.1, 2.0)  
Female Reference Reference 
Married/cohabitation   
Yes 1.5 (1.1, 2.1)  1.4 (1.0, 2.0)  
No Reference Reference 
Body Mass Index
a
 1.1 (1.1, 1.2) 1.1 (1.0, 1.1) 
Use Mobility Device   
Yes  1.4 (1.1, 1.9) 1.3 (0.9, 1.8) 
No Reference Reference 
Pain in the Last Month   
Yes 1.8 (1.3, 2.4) 1.4 (1.0, 2.0) 
No Reference Reference 
Cardiovascular Disease   
Yes 1.6 (1.1, 2.4) 1.1 (0.7, 1.7) 
No Reference Reference 
Diabetes    
Yes 2.2 (1.5, 3.1) 1.3 (1.0, 1.9) 
No Reference Reference 
OSA=Obstructive Sleep Apnea; NHATS=National Health and Aging Trends Survey; CI=Confidence Interval; N/A=not 
included in multivariate model; 
a
 The odds ratio of BMI represents the association for a one-unit increase in BMI on the odds 
of OSA diagnosis. For example, the odds of carrying an OSA diagnosis for an individual with BMI=30, is (1.1)
4
=1.46 times 
that of an individual with BMI=26 
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Figure 1 legend: Proportion of OSA recognition and treatment among ‘At Risk’ NHATS 
participants (PSG=polysomnography, HSAT=home sleep apnea testing); N=1,052 respondents 
reflects the unweighted sample frequencies that represent 7,082,963 older Americans in the 




Supplementary table S1: NHATS and corresponding STOP-Bang items 
 
Supplementary table S2: Sleep characteristics of NHATS participants by OSA risk and evaluation 
with home or in-laboratory sleep apnea testing 
 
Supplementary table S3: Coding scheme for OSA evaluation (CPT codes), OSA diagnosis (ICD- 
9 codes), and PAP equipment codes (HCPCS codes) 
 
Supplementary Figure S4: Flow Chart of participants in the National Health and Aging Trends 
Survey (NHATS) 2013; In the final analytic sample, the 1,052 respondents reflect the unweighted 
sample frequencies and represent 7,082,963 older Americans in the general population. 
 
Supplementary Figure S5: Proportion of OSA recognition and treatment among ‘At Risk’ 
NHATS participants (PSG=polysomnography, HSAT=home sleep apnea testing) after scoring 
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the age item as “0” to assess the potential influence of the age item toward OSA risk. N=1,052 
respondents reflects the unweighted sample frequencies that represent 7,082,963 older 
Americans in the general population. 
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t   Supplementary table S1: NHATS and corresponding STOP-Bang items  
NHATS  
Item #  
 Round 3 Sleep Module Questions 








SL5  In the last month, how often did 
you have trouble staying asleep 
because you snored loudly, or you 
woke up gasping or choking? 
Would you say every night (1), 
most nights (2), some nights (3), 
rarely (4), or never (5)? 
a
  
- Do you snore 





your sleep?  
Yes=8%            No=89%  
SL8  In the last month, how often did 
you have trouble staying awake at 
times during the day when you 
wanted to be awake? Would you 
say every day (1), most days (2), 









Yes=37%          No=60%  
Selected questions from NHATS Round 3  
IS4  Are you male or female?  - Gender male?  Male=43%   
Female=57%  
IS5  I also want to confirm your birth 
date is  
(BIRTH MONTH BIRTH DAY, 
BIRTH  
YEAR). Is that correct?  
- Age over 50 
years old?  
>50 years=100%  
HC2  I will read a list of some diseases 
and conditions that a doctor may 
have said you have. Please tell me 
if a doctor ever told you that you 
had - RESPONSE [3] C. high blood 
pressure or hypertension?  
- Do you have or 
are you being 
treated for high 
blood pressure?  
Yes=69%          No=31%  
HW2  How much do you currently weigh?  
HeightFeet                       
HeightInch  
-BMI > 35 kg/m
2
?  Yes=9%            No=91%  
HW7  
HW8  
Positive NHATS items were summed to yield total surrogate STOP-Bang score. With the exception of item SL5 
(in which positive responses correspond to 2 STOP-Bang questions and were therefore allowed 2 points) each 
positive NHATS response equates to 1 point on the STOP-Bang. No NHATS item that corresponded to STOP-
Bang neck circumference item was available. 
a 
Scores of 1,2 or 3 were classified as positive responses.  
b 
Missing  ≤3%   
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tSupplementary table S2: Sleep characteristics of NHATS participants by OSA risk and evaluation with home or in-laboratory sleep apnea testing 
Sleep characteristics  Low OSA risk  Elevated OSA risk  






Not evaluated (%)  
Sleep Duration (hours)          
   ≤5   48  11  4  13  
   6    17  18  20  19  
   7-8  35  58  71  55  
   ≥9  0  12  5  13  
Initial Insomnia          
  Yes   43  20  18  23  
  No  57  80  82  77  
Maintenance Insomnia          
  Yes   46  10  11  17  
  No    54  90  89  83  
Habitual napping          
  Yes   22  18  42  33  
  No  88  82  58  67  
Poor Sleep Quality          
  Yes  53  5  3  10  
  No   47  95  97  90  
Use of Hypnotics          
  Yes   54  19  28  27  
  No  46  81  72  73  
OSA=Obstructive sleep apnea  
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tSupplementary table S3: Coding scheme for OSA evaluation (CPT codes), OSA diagnosis 
(ICD-9 codes), and PAP equipment codes (HCPCS codes) 
OSA Evaluation  G0398 (home sleep study)  
  G0399 (home sleep study)  
  G0400 (home sleep study)  
  95800 (sleep study, unattended)  
  95801 (sleep study, unattended)  
  95806 (sleep study, unattended)  
  95807 (sleep study, attended)  
  95808 (PSG)  
  95810 (in-lab PSG)  
  95811 (PAP titration)  
OSA Diagnosis  327.23 (OSA)  
  327.20 (organic sleep apnea, unspecified)  
  780.57 (unspecified sleep apnea)  
  780.53 (hypersomnia with sleep apnea, unspecified)  
  780.51 (insomnia with sleep apnea, unspecified)  
OSA Treatment  E0601 (CPAP, auto CPAP)  
  E0470 (ResMed S9VPAP Adapt)  
  E0470 (Bilevel, auto bilevel)  
  E0471 (Bilevel with backup rate)  
  E0562 (heated humidifier)  
  A7035 (headgear)  
  A7034 (nasal mask)  
  A7030 (full face mask)  
  A7027 (oral/nasal mask)  
  A7033 (nasal pillows)  
  A7037 (tubing)  
  A7038 (disposable filters)  
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